Pressmeddelanden, rapporter och bolagsmeddelande för Curasight
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Positive results in uPAR-PET/MR Phase II study in brain cancer
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight A/S reports positive preclinical results with uTREAT[®] in aggressive brain cancer (glioblastoma)
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight to present at HC Andersen Capital and Økonomisk Ugebrev
Spotlight News
Nyhetsuppdatering från Curasight
Reports: Interim report Q1 2023
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight and Curium announce global partnership for uTRACE[®] in prostate cancer
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Resolutions of the Annual General Meeting of Curasight A/S
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Notice of Annual General Meeting 2023
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Annual Report for the fiscal year 2022
Spotlight News
Nyhetsuppdatering från Curasight
Reports: Year-end report October - December 2022
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight to present at HC Andersen Capital